Staphylococcus Epidermidis

Antibiogram - Staphylococcus epidermidis
Number of Isolates Identified - 411
Back to List of Organisms
SusceptibleIsolates Tested
Ampicillin (Am) 0 411
Amikacin (Ak)    
Amoxicillin/clavulanate (Aug) 50 162
Ampicillin/sulbactam (A/S) 50 162
Cefotaxime (Cft) - Non-meningitis    
Cefotaxime (Cft) - Meningitis    
Ceftriaxone (Cax)    
Clindamycin (Cd) 66 411
Ciprofloxacin (Cp) 56 162
Daptomycin (Dap) 100 411
Erythromycin (E) 48 411
Gatifloxacin (Gat)    
Gentamicin (Gm) 85 411
Gentamicin 500 (Gm 500)    
Levofloxacin (Lvx) 61 411
Linezolid (Lzd) 100 411
Moxifloxacin (Mxf)    
Nitrofurantoin (Fd) 100 411
Oxacillin (Ox) 42 411
Penicillin-G (P) 6 411
Rifampin (R/F) 99 411
Quinupristin-dalfopristin (Syn)    
Streptomycin 2000 (ST2000)    
Tetracycline (Te) 84 411
Trimethoprim/sulfa (T/S) 59 411
Vancomycin (Va) 100 411

To read this antibiogram:

  1. Each antibiotic is presented in three columns. The first column lists the name of the antibiotic. The middle column represents susceptibility in percent to that antibiotic. The 3rd column represents the number of isolates tested for that specific antibiotic.
  2. Susceptibility greater than or equal to 90% is highlighted in GREEN, 60%-89% in YELLOW, and less than 60% in RED. Susceptibility not reaching 100% is also labeled as 99%.
  3. Nitrofurantoin is tested for urine specimens only.
  4. The susceptibility result for Streptococcus pneumoniae is a combination of screening test and E-test results.
  5. CLSI performance standards for antimicrobial susceptibility testing were applied. CLSI stands for Clinical and Laboratory Standards Institute (Formerly NCCLS, The National Committee for Clinical Laboratory Standards).
  6. Empty cells indicate that susceptibility testing for that specific organism and antibiotic is not recommended or complete testing data was not available or the number is too small for a valid reporting.